Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Roche's Phase 2 results made a worthy contribution in CT-388
Date 30 January 2026

Roche's Phase 2 results made a worthy contribution in CT-388

Introduction Roche Company is a diagnostics and pharmaceuticals champion straight from the Swiss land. The company has marked its position in the healthcare sector for its personalised solutions, mai...

Merz's confident submission to EMA
Date 29 January 2026

Merz's confident submission to EMA

Introduction Merz Therapeutics is a family renowned specialty pharmaceutical company smartly developing and introducing effective therapies for movement disorders, liver disease and neurological cond...

Parkinson's Promising Therapies
Date 29 January 2026

Parkinson's Promising Therapies

Introduction Parkinson’s disease (PD), a neurological disorder, takes place due to the brain’s low capacity to generate required dopamine, showing symptoms such as slowness, plus non-moto...

Corcept's Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy
Date 29 January 2026

Corcept's Clinical Ecosystem to upgrade with its Ovarian Cancer Drug Efficacy

Introduction Corcept Therapeutics, a popular commercial-driven pharmaceutical company known for its main cortisol modulators, heals extreme oncologic, neurological, metabolic, and endocrinologic cond...

Myllia's Echoes of Silenced Genes: positive noise in CRISPR perturbation
Date 28 January 2026

Myllia's Echoes of Silenced Genes: positive noise in CRISPR perturbation

Introduction Myllia Biotechnology is a champion in merging bandwidth, CRISPR screening, and single-cell RNA sequencing. The company is popular as ‘Aelian Biotechnology’ along with its adv...

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia
Date 27 January 2026

IntraBio, baby steps for the treatment of Ataxia-Telangiectasia

Introduction IntraBio Inc. operates in the healthy air of Austin, Texas, with its innovative treatment development for common and rare neurodegenerative conditions. The company sharpens its smartness...

Tanabe's positive results bring life to EPP and XLP patients
Date 23 January 2026

Tanabe's positive results bring life to EPP and XLP patients

Introduction Tanabe Pharma America, Inc., formerly Mitsubishi Tanabe Pharma America, is a U.S. division of Japan’s Tanabe Pharma Corporation. The company is known for its marketing skills and i...

Adolore's Kv7-activating rdHSV-CA8 Therapy, now qualified for Erythromelalgia treatment
Date 20 January 2026

Adolore's Kv7-activating rdHSV-CA8 Therapy, now qualified for Erythromelalgia treatment

Introduction Adolore BioTherapeutics, a leading biotech face known for its consistent efforts for establishing gene-therapy related treatments for chronic pain with the help of creative and safe CA8 ...

Hyundai Bioscience is getting closer to its Antiviral, XAFTY trial process succession
Date 20 January 2026

Hyundai Bioscience is getting closer to its Antiviral, XAFTY trial process succession

Introduction Hyundai Bioscience, a well-known biotechnology company highly focused on establishing novel drug delivery systems (DDS) to advance and contribute to the existing drugs to spot precision ...

Vy Spine to straighten its walk confidently with the FDA clearance for the VyBrate VBR System
Date 16 January 2026

Vy Spine to straighten its walk confidently with the FDA clearance for the VyBrate VBR System

Introduction Vy Spine is a champion known for its exceptional designs and materials. This innovation leader was introduced to the healthcare sector via active internal development and the new qualifi...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.